You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

blocker

Showing 1 - 25 of 2,429
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronary Artery Bypass Trial in New Haven (Discontinuing all beta-blocker)

Recruiting
  • Coronary Artery Bypass
  • Discontinuing all beta-blocker
  • New Haven, Connecticut
    Yale New Haven Hospital
Nov 17, 2022

Spleen Stiffness asMeasure to Assess REsponse to ß Blocker

Not yet recruiting
  • High Risk Esophageal Varices
  • No intervention
  • New Delhi, Delhi, India
    Institute of Liver & Biliary Sciences
Sep 16, 2023

Long-term Use of CCB and Breast Cancer Risk

Active, not recruiting
  • Hypertension,Essential
  • Breast Cancer
  • Calcium channel blocker
  • +5 more
  • Bentley, Western Australia, Australia
    Curtin university
Aug 1, 2023

Atrial Fibrillation, Diastolic Dysfunction, HFpEF - Heart Failure With Preserved Ejection Fraction Trial in Burlington (As

Recruiting
  • Atrial Fibrillation
  • +2 more
  • As needed pharmacological rate control with beta-blocker (metoprolol tartrate, metoprolol succinate) or calcium channel blocker (diltiazem, verapamil)
  • Burlington, Vermont
    University of Vermont Medical Center
Feb 28, 2023

Lung Diseases Trial in Istanbul (Tappa Endobronchial Blocker, Arndt Endobronchial Blocker)

Not yet recruiting
  • Lung Diseases
  • Tappa Endobronchial Blocker
  • Arndt Endobronchial Blocker
  • Istanbul, Turkey
    Istanbul University
Jun 9, 2022

Laryngopharyngeal Reflux Disease Trial in Pusan (Tegoprazan, Placebo)

Completed
  • Laryngopharyngeal Reflux Disease
  • Pusan, Korea, Republic of
    Pusan National University Hospital
May 12, 2023

Coarctation of Aorta, High Blood Pressure Trial in Rochester (Losartan, Amlodipine, Placebo)

Not yet recruiting
  • Coarctation of Aorta
  • High Blood Pressure
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 21, 2023

Discoloration, Tooth Trial (single-shade universal resin composite (omnichroma) with blocker( omnichroma blocker))

Not yet recruiting
  • Discoloration, Tooth
  • single-shade universal resin composite (omnichroma) with blocker( omnichroma blocker)
  • (no location specified)
Jul 18, 2022

Alcohol Drinking Trial in New Haven (Propranolol, Placebo)

Recruiting
  • Alcohol Drinking
  • New Haven, Connecticut
    Yale University School of Medicine
Jan 12, 2023

Cirrhosis, Decompensated Cirrhosis, Portal Hypertension Trial (EUS)

Not yet recruiting
  • Cirrhosis
  • +2 more
  • EUS
  • (no location specified)
Nov 13, 2022

Giant T-wave Electrical Alternans Trial (Mexiletine, Conventional therapy)

Not yet recruiting
  • Giant T-wave Electrical Alternans
  • (no location specified)
Dec 28, 2022

Migraine Prophylaxis Trial in Dhaka (Nicotinic Acid 500 MG Extended Release Oral Tablet, Nicotinic Acid 1000 MG Extended Release

Recruiting
  • Migraine Prophylaxis
  • Nicotinic Acid 500 MG Extended Release Oral Tablet
  • +2 more
  • Dhaka, Bangladesh
    BSMMU
May 5, 2023

Myocardial Infarction Trial in Paris (Beta-blockers withdrawal, Continuation of the Betablockers (ßB) treatment)

Active, not recruiting
  • Myocardial Infarction
  • Beta-blockers withdrawal
  • Continuation of the Betablockers (βB) treatment
  • Paris, France
    Institut de Cardiologie - USIC - Hôpital Pitié-Salpêtrière
Oct 28, 2022

Atrial Fibrillation, Left Atrial Rhythm Trial in Monastir (Digoxin 0.25 mg, Bisoprolol)

Recruiting
  • Atrial Fibrillation
  • Left Atrial Rhythm
  • Monastir, Tunisia
    Fattouma Bourguiba University hospital
Sep 14, 2022

End-Stage Kidney Disease, End-Stage Renal Disease Trial in Boston, Minneapolis, New York (Metoprolol Succinate, Carvedilol)

Not yet recruiting
  • End-Stage Kidney Disease
  • End-Stage Renal Disease
  • Boston, Massachusetts
  • +4 more
Jun 26, 2023

Atrial Fibrillation Trial in Taipei (Reduced dosage of beta-blocker)

Recruiting
  • Atrial Fibrillation
  • Reduced dosage of beta-blocker
  • Taipei, Taiwan
    National Taiwan University Hospital
Apr 19, 2022

Angina, Stable Ischemic Heart Disease Trial in United States (Clinician Discretion, Beta blocker, Calcium channel blocker)

Not yet recruiting
  • Angina
  • Stable Ischemic Heart Disease
  • Clinician Discretion
  • +2 more
  • Oakland, California
  • +4 more
Mar 23, 2023

Blind Tracheal Intubation Through Supraglottic Airway Devices

Recruiting
  • Respiration and the Airways With Laryngeal Masks
  • Air-QTM Blocker
  • LarySealTM Pro
  • Cairo, Egypt
  • +1 more
Nov 18, 2022

Heart Failure With Preserved Ejection Fraction Trial in Farmington (beta blocker discontinuation)

Recruiting
  • Heart Failure With Preserved Ejection Fraction
  • beta blocker discontinuation
  • Farmington, Connecticut
    UConn Health / John Dempsey Hospital
Mar 2, 2022

Dilated Cardiomyopathies, Idiopathic, Heart Failure, Systolic, Ventricular Remodeling Trial in Aurora, Columbus (Ivabradine,

Active, not recruiting
  • Dilated Cardiomyopathies, Idiopathic
  • +3 more
  • Aurora, Colorado
  • +1 more
Oct 31, 2022

Heart Failure, Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction Trial in New York (Beta blocker)

Recruiting
  • Heart Failure
  • +4 more
  • Beta blocker
  • New York, New York
    Weill Cornell Medicine
Jan 31, 2023

Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists Trial in Limoges (Valsartan, Placebo Oral Tablet)

Not yet recruiting
  • Aortic Valve Stenosis
  • +5 more
  • Limoges, France
    Limoges university hospital
Dec 23, 2022

Tetralogy of Fallot Trial in Pittsburgh (other, procedure, drug)

Not yet recruiting
  • Tetralogy of Fallot
  • N-thymidine
  • +7 more
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Jul 5, 2022

Trauma, Brain Trial in Shibin Al Kawm (Propranolol, Saline)

Recruiting
  • Trauma, Brain
  • Shibīn Al Kawm, Menoufia, Egypt
    Faculty of Medicine, University Hospitals
Apr 4, 2022

Myocardial Infarction Trial in Seoul (Discontinuation of ß-blocker)

Recruiting
  • Myocardial Infarction
  • Discontinuation of β-blocker
  • Seoul, Korea, Republic of
    Samsung Medical Center
May 8, 2022